01 noviembre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Treatment of TASC C and D Femoropoliteal Lesions with Paclitaxel eluting Stents: 12 month Results of the STELLA-PTX Registry

J.-M. Davaine, J. Querat, A. Kaladji, B. Guyomarch, P. Chaillou, A. Costargent, T. Quillard, Y. Gouëffic

Objective: The aim was to evaluate the safety and the efficacy of primary stenting with paclitaxel eluting stents for TASC C and D femoropopliteal lesions.

01 octubre 2015

EUROPEAN JOURNAL OF VASCULAR & ENDOVASCULAR SURGERY. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent

M.A.F. de Wolf, R. de Graaf, R.L.M. Kurstjens, S. Penninx, H. Jalaie, C.H.A. Wittens

Objective: Deep venous stenting has become the primary treatment option for chronic venous obstructive disease, both for iliac vein compression and post-thrombotic venous lesions. Until recently, only stents aimed at arterial pathology were used, because no dedicated venous stents were available. However, three such stents have now become available. These venous stents are characterized by increased length, diameter, flexibility, and radial force. This study reports an early experience with one of these devices; the sinus Venous stent (OptiMed GmbH, Ettlingen, Germany).

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Role of coexisting contralateral primary venous disease in development of post-thrombotic syndrome following catheter-based treatment of iliofemoral deep venous thrombosis

John J. Lee, MD, Mustafa Al-Jubouri, MD, Robin Acino, MPH, Anthony J. Comerota, MD, FACS, FACC, Fedor Lurie, MD, PhD

Background: It has been reported that early clot removal benefits patients with iliofemoral deep venous thrombosis (DVT) by removing obstruction and preserving valve function. However, a substantial number of patients who had successful clot removal develop post-thrombotic syndrome (PTS). Residual thrombus and rethrombosis play a part in this phenomenon, but the role of coexisting primary chronic venous disease (PCVD) in these patients has not been studied.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Association between inflammation biomarkers, anatomic extent of deep venous thrombosis, and venous symptoms after deep venous thrombosis

Anat Rabinovich, MD, Jacqueline M. Cohen, PhD, Mary Cushman, MD, Susan R. Kahn, MD, MSc

Objective: Inflammation may play a role in pathogenesis of venous thromboembolism, but the nature of this relationship is not yet understood. The objective of this study was to assess whether inflammation marker levels measured at diagnosis of deep venous thrombosis (DVT) and change in levels during the first month after DVT are associated with anatomic extent of DVT and severity of venous signs and symptoms at baseline and 1 month.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Morphologic changes in the vein after different numbers of radiofrequency ablation cycles

Evgeny V. Shaidakov, MD, PhD, Arsen G. Grigoryan, MD, Dmitriy E. Korzhevskii, MD, PhD, Evgeny A. Ilyukhin, MD, Dmitriy A. Rosukhovski, MD, Vasiliy L. Bulatov, MD, Oleg I. Tsarev, MD, PhD

Objective: It has not yet been clarified whether it is possible to decrease the percentage of recurrences after radiofrequency (RF) ablation by way of increasing the number of RF ablation cycles. The aim of this study was to assess the morphologic changes in excised vein fragments after different durations of RF ablation exposure.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Complications with office-based venoplasties and stenting and their clinical correlation

Arkady Ganelin, MD, Anil Hingorani, MD, Enrico Ascher, MD, Borislav Kheyson, MD, Eleanora Iadgarova, RN, Natalie Marks, MD, Yuriy Ostrozhynskyy

Background: Endovenous therapy by venoplasty and stenting is rapidly gaining momentum and popularity in treatment of chronic venous insufficiency (nonthrombotic iliac vein lesions, in particular). The purpose of this study was to examine the results of office-based venoplasty and stenting procedures that were performed at our office-based facility from July 28, 2012, until April 28, 2013. The study focused on any complications during and after the procedure.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Technical considerations, outcomes, and durability of inferior vena cava stenting

Javairiah Fatima, MD, AbdulAziz AlGaby, MD, James Bena, Mohammad N. Abbasi, MD, Daniel G. Clair, MD

Objective: Inferior vena cava (IVC) thrombosis is an uncommon condition but can cause devastating complications to those affected. Historically, this has been treated with an open surgical approach (with high morbidity) and with angioplasty in more recent years. Herein we describe technical aspects of stenting of the IVC in patients with recalcitrant chronic occlusive disease and evaluate its outcomes.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Treatment of nutcracker syndrome with open and endovascular interventions

Young Erben, MD, Peter Gloviczki, MD, Manju Kalra, MBBS, Haraldur Bjarnason, MD, Nanette R. Reed, MD, Audra A. Duncan, MD, Gustavo S. Oderich, MD, Thomas C. Bower, MD

Objective: Nutcracker syndrome (NS) is a rare cause of hematuria, flank pain, and renal venous hypertension due to compression of the left renal vein (LRV) between the aorta and the superior mesenteric artery. To evaluate outcomes of open surgery and endovascular interventions, we reviewed our experience.

01 noviembre 2015

JOURNAL OF VASCULAR SURGERY. Predictors of restenosis in the use of helical interwoven nitinol stents to treat femoropopliteal occlusive disease

Yiu Che Chan, MBBS, MD, FRCS, Stephen W. Cheng, MBBS, MS, FRCS, Grace C. Cheung, MMedSc

Background: The femoropopliteal arteries are subjected to considerable axial and bending deformity due to flexion at the hip and knee joints. The Supera helical interwoven nitinol stent system (IDEV Technologies, Inc/Abbott Laboratories, Inc, Webster, Tex) has good conformability and flexibility, with a very low incidence of mechanical fatigue. This study reviewed our experience with the use of Supera stents for femoropopliteal atherosclerotic lesions and identified risk factors for restenosis or occlusion.

01 noviembre 2015

JOURNAL OF VASCULAR SURGERY. Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions

Michele Piazza, MD, Francesco Squizzato, MD, Gaya Spolverato, MD, Luca Milan, MD, Stefano Bonvini, MD, Mirko Menegolo, MD, Franco Grego, MD, Michele Antonello, MD

Objective: This study compared early and midterm outcomes of polytetrafluoroethylene-covered stents (CSs) vs bare-metal stents (BMSs) in the primary treatment of severe TransAtlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) C and D iliac artery obstructive lesions.

01 noviembre 2015

JOURNAL OF VASCULAR SURGERY. Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal

Christopher J. Kwolek, MD, Michael R. Jaff, DO, J. Ignacio Leal, MD, L. Nelson Hopkins, MD, Rasesh M. Shah, MD, Todd M. Hanover, MD, Sumaira Macdonald, MD, Richard P. Cambria, MD

Objective: This report presents the 30-day results of the Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure (ROADSTER) multicenter trial and evaluates the safety and efficacy of ENROUTE Transcarotid NPS (Silk Road Medical Inc, Sunnyvale, Calif), a novel transcarotid neuroprotection system that provides direct surgical common carotid access and cerebral embolic protection via high-rate flow reversal during carotid artery stenting (CAS).

01 noviembre 2015

JOURNAL OF VASCULAR SURGERY. Treatment of iliac artery bifurcation aneurysms with the second-generation straight iliac bifurcated device

Andreas G. Loth, MD, Guido Rouhani, MD, Sameer A. Gafoor, MD, Horst Sievert, MD, PhD, Wolf J. Stelter, MD, PhD

Background: There are few long term studies to show the safety and efficacy of iliac artery aneurysm exclusion, especially in regards to the straight iliac branched device. The objective of our study was to add our data with a mean follow-up of 32 months to the existing data available.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Evaluation of the Zenith low-profile abdominal aortic aneurysm stent graft

Jonathan Sobocinski, MD, PhD, Florent Briffa, MD, Peter J. Holt, MD, FRCS, Teresa Martin Gonzalez, MD, Rafaëlle Spear, MD, PhD, Richard Azzaoui, MD, Blandine Maurel, MD, PhD, Stéphan Haulon, MD, PhD

Background: Low-profile (LP) stent grafts are now commercially available in Europe for endovascular aortic aneurysm repair (EVAR). In this study the midterm outcomes and characteristics of patients treated with this last generation of stent grafts were compared with a cohort of patients treated with “standard-profile” (SP) stent grafts.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Performance of the Endurant stent graft in patients with abdominal aortic aneurysms independent of their morphologic suitability for endovascular aneurysm repair based on instructions for use

Konstantinos P. Donas, MD, Giovanni Torsello, MD, Kristin Weiss, MD, Theodosios Bisdas, MD, Markus Eisenack, MD, Martin Austermann, MD

Objective: The aim of this study was to prospectively evaluate the early and late 7-year experience with the Endurant bifurcated stent graft system (Medtronic, Santa Rosa, Calif) in patients with abdominal aortic aneurysms.

01 octubre 2015

JOURNAL OF VASCULAR SURGERY. Management of late main-body aortic endograft component uncoupling and type IIIa endoleak encountered with the Endologix Powerlink and AFX platforms

Afshin A. Skibba, MD, James R. Evans, MD, David Tyler Greenfield, MD, Heesuk Richard Yoon, MD, Tony Katras, MD, Kenneth Ouriel, MD, Daniel S. Rush, MD

Objective: Junctional component separation producing type IIIa endoleak after endovascular abdominal aortic aneurysm repair (EVAR) is an uncommon but serious complication requiring unanticipated reinterventions. This retrospective study analyzed main-body EVAR component uncoupling and type IIIa endoleaks encountered with Powerlink and AFX (Endologix Inc, Irvine, Calif) endografts during an 8-year period.